Event Group / Wellcome Trust / Amphotericin B (N = 99) Group / Amphotericin B (N = 99) Characteristic Group / Amphotericin B (N = 99) Outcome Group / British Infection Society / Cox / Valeant Pharmaceuticals France / Flucytosine (N = 100) Group / Cipla / Group 1 P Value Group / Ranbaxy Laboratories / Treatment Group / /
Continent
Asia / /
Country
Vietnam / United Kingdom / / /
Facility
Oxford University / ART clinic / /
Holiday
between day / /
IndustryTerm
study protocol / /
MedicalCondition
HIV / Headache / urinary retention / flu / liver failure / nausea / Thrombocytopenia / severe anemia / Hyponatremia / cryptococcal meningitis / then received flu / diarrhea / hematemesis / high-dose flu / Had cryptococcosis / illness / infections / cryptococcosis / sepsis / Papilledema / thrombophlebitis / disease / Cranial-nerve palsy / Cryptococcal Meningitis Jeremy N. Day / Pneumocystis jirovecii pneumonia / neutropenia / either flu / Cryptococcal Meningitis Between-group / Fever / Seizure / vomiting / Opportunistic infection / oral flu / concurrently received flu / infection / human immunodeficiency virus infection / Hypokalemia / Rash / meningitis / anemia / /
MedicalTreatment
Antiretroviral therapy / antifungal therapy / /
Organization
Liverpool School of Tropical Medicine / Hospital for Tropical Diseases / Oxford University / /
Person
Tran T.H. Chau / Marcel Wolbers / Jeremy N. Day / Cao Q. Thai / Nguyen H. Mai / Ho D. Nghia / Pham T. Diep / James I. Campbell / Van A. Duong / Nguyen H. Phu / Ly V. Chuong / Jeremy J. Farrar / H. Thai / Pham P. Mai / Nguyen T. Dung / Dinh X. Sinh / Nguyen V.V. Chau / David G. Lalloo / Nguyen D. Phong / Stephen G. Baker / N. Hoang / Tran T. Hien / Van Kiet / /